Opportunities for accelerating innovation and mitigating risk at the nexus of IP and R&D

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Opportunities for accelerating innovation and mitigating risk at the nexus of IP and R&D

Sponsored by

Logo 22.07.22.png
Vector circle tech with light blue and lamp bulb on technology b

The CAS IP Research Team analyse how organisations are applying IP insights to accelerate scientific breakthroughs and identify potential risks to commercialisation

The transformation of IP management within commercial companies is driving the adoption of new practices and technologies to more closely align IP objectives with growth strategies, unlock greater portfolio value, and support strategic decision-making across enterprises.

This research white paper from CAS explores this transformation at the nexus of IP and research and development (R&D), where organisations are applying IP insights to accelerate scientific breakthroughs and identify potential risks to commercialisation earlier in the product lifecycle.

Missing critical IP information during R&D can lead to misallocated resources, potential patent entanglements downstream, and delays in commercialisation. The white paper provides valuable insights for R&D and IP managers about these critical topics:

  • Top IP management goals over the next 12 months;

  • Role and use of IP information across organisations;

  • Challenges in using IP information; 

  • State of IP information access and investments; and 

  • Resolving IP information gaps 

Click here to access CAS’s white paper – “Opportunities for Accelerating Innovation and Mitigating Risk at the Nexus of Intellectual Property and R&D”

Click here to access CAS’s content hub on Managing IP

more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article